Certified by Founder
Lodge
Outrun Therapeutics
start up
United Kingdom
- Dundee, Scotland
- 19/04/2024
- Seed
- $10,000,000
Outrun Therapeutics is unlocking the therapeutic potential of protein stabilisation by E3 Ligase inhibition for the treatment of cancer and other diseases.
- Industry Biotechnology Research
- Website https://outruntx.com/
- LinkedIn https://www.linkedin.com/company/outrun-therapeutics/
Related People
Carolyn PorterFounder
United Kingdom -
Greater Oxford Area
25 years of leadership experience, including in the spin-out arena, having led the formation of 16 companies raising £52M cumulatively in seed financing while at Oxford University. Held Board positions in several biotech companies and formerly held Business Development roles in big pharma (Novartis) and big biotech(Chiron).
Specialties: Key skills include business development, deal negotiation and execution, strategic, market and business analysis, people management and project management.
Forage | $40,000,000 | (Jun 5, 2026)
InCharge Energy | $46,000,000 | (Jun 5, 2026)
Oak Hill Bio | $32,500,000 | (Jun 5, 2026)
ZutaCore | $100,000,000 | (Jun 5, 2026)
Terra AI | $20,000,000 | (Jun 5, 2026)
Town | $55,000,000 | (Jun 5, 2026)
Lassie | $35,000,000 | (Jun 5, 2026)
OFFROAD | $7,000,000 | (Jun 5, 2026)
Shifters | $10,200,000 | (Jun 5, 2026)
Quobly | $133,545,475 | (Jun 5, 2026)
Scispot | $8,000,000 | (Jun 5, 2026)
Scotch | $20,000,000 | (Jun 5, 2026)